Acumen Pharmaceuticals CEO Daniel O'Connell's 2022 pay jumps 80% to $2.7M
Acumen Pharmaceuticals reports 2022 executive compensation
By ExecPay News
Published: April 27, 2023
Acumen Pharmaceuticals reported fiscal year 2022 executive compensation information on April 27, 2023.
In 2022, three executives at Acumen Pharmaceuticals received on average a compensation package of $1.7M, a 77% increase compared to previous year.
Average pay of disclosed executives at Acumen Pharmaceuticals
Daniel O'Connell, Chief Executive Officer, received $2.7M in total, which increased by 80% compared to 2021. 66% of O'Connell's compensation, or $1.8M, was in option awards. O'Connell also received $291K in non-equity incentive plan, $570K in salary, as well as $40K in other compensation.
Derek Meisner, Chief Legal Officer, received a compensation package of $1.3M. 81% of the compensation package, or $1M, was in option awards.
Matthew Zuga, Chief Financial Officer, earned $1.2M in 2022, a 53% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 27, 2023.